4.3 Article

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

Journal

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
Volume 37, Issue -, Pages 145-152

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ctro.2022.10.002

Keywords

Stereotactic Radiotherapy; Lung cancer; Quality assurance

Funding

  1. Canadian Cancer Society Research Institute Impact Grant
  2. [701596]

Ask authors/readers for more resources

This study reports on the credentialing experience of SBRT during the OCOG LUSTRE trial. The results showed inconsistent OAR definitions across centers, and institutions with limited SBRT experience were more likely to violate protocol guidelines.
Purpose: To report on the Stereotactic Body Radiation Therapy (SBRT) credentialing experience during the Phase III Ontario Clinical Oncology Group (OCOG) LUSTRE trial for stage I non-small cell lung cancer.Methods: Three credentialing requirements were required in this process: (a) An institutional technical survey; (b) IROC (Imaging and Radiation Oncology Core) thoracic phantom end-to-end test; and (c) Contouring and completion of standardized test cases using SBRT for one central and one peripheral lung cancer, compared against the host institution as the standard. The main hypotheses were that unacceptable variation would exist particularly in OAR definition across all centres, and that institutions with limited experience in SBRT would be more likely to violate per-protocol guidelines.Results: Fifteen Canadian centres participated of which 8 were new, and 7 were previously established (>= 2 years SBRT experience), and all successfully completed surveys and IROC phantom testing. Of 30 SBRT test plans, 10 required replanning due to major deviations, with no differences in violations between new and established centres (p = 0.61). Mean contouring errors were highest for brachial plexus in the central (C) case (12.55 +/- 6.62 mm), and vessels in the peripheral (P) case (13.01 +/- 12.55 mm), with the proximal bronchial tree (PBT) (2.82 +/- 0.78 C, 3.27 +/- 1.06 P) as another variable structure. Mean dice coefficients were lowest for plexus (0.37 +/- 0.2 C, 0.37 +/- 0.14 P), PBT (0.77 +/- 0.06 C, 0.75 +/- 0.09 P), vessels (0.69 +/- 0.29 C, 0.64 +/- 0.31 P), and esophagus (0.74 +/- 0.04 C, 0.76 +/- 0.04 P). All plans passed per-protocol planning target volume (PTV) coverage and maximum/ volumetric organs-at-risk constraints, although variations existed in dose gradients within and outside the target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available